Please try another search
Renovaro Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and cancer in the United States. The company’s product pipeline includes RENB-HV-01 for autologous HIV curative treatment; RENB-HV-12, a therapeutic HIV vaccine; and RENB-HB-01, a gene therapy curative treatment for HBV. It also develops RENB-DC-11, an allogeneic dendritic cell therapeutic vaccine for pancreatic cancer; RENB-DC-12-XX, an allogeneic dendritic cell therapeutic vaccine for other solid tumors; and RENB-HV-21 for treating HIV with allogeneic natural killer (NK) and gamma delta T-cells. It has strategic partnerships with the University of California, Fred Hutchinson Cancer Research Center, and Caring Cross. The company was formerly known as Renovaro Biosciences Inc. and changed its name to Renovaro Inc. in February 2024. Renovaro Inc. is headquartered in Los Angeles, California.
Name | Age | Since | Title |
---|---|---|---|
W. David Hardy | - | 2018 | Chairman of HIV Scientific Advisory Board |
James R. Sapirstein | 62 | 2018 | Independent Director |
Mark R. Dybul | 60 | 2018 | CEO, Director & Member of HBV Scientific Advisory Board |
Gregg Huber Alton | 57 | 2019 | Lead Independent Board Member |
Jayne McNicol | 56 | 2021 | Independent Director |
Carol L. Brosgart | 71 | 2019 | Chairperson of HBV Cure Scientific Advisory Board & Independent Director |
Rene Sindlev | 61 | 2017 | Chairman of the Board |
Steven G. Deeks | - | 2018 | Member of HIV Scientific Advisory Board |
Fabien Zoulim | - | 2020 | Member of HBV Scientific Advisory Board |
Anna Suk-fong Lok | - | 2021 | Member of HBV Scientific Advisory Board |
Richard James Whitley | 78 | 2021 | Member of Respiratory Diseases Scientific Advisory Board |
Peter Revill | - | 2020 | Member of HBV Scientific Advisory Board |
Rudolphus Gabriel Cornelis Hendriks | 77 | 2023 | Independent Director |
Avram C. Miller | 79 | 2023 | Director |
Karen Brink | - | 2024 | Director |
Leni Maria Teuntje Boerner | 61 | 2023 | Independent Director |
Geert Kazemier | - | 2024 | Chairman of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review